Septerna, Inc. (SEPN)
41.86
-6.70
(-13.80%)
USD |
NASDAQ |
Nov 12, 16:00
41.27
-0.59
(-1.41%)
After-Hours: 20:00
Septerna Enterprise Value : 1.528B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.528B |
| November 11, 2026 | 1.846B |
| November 10, 2026 | 2.025B |
| November 09, 2026 | 1.949B |
| November 06, 2026 | 1.859B |
| November 05, 2026 | 1.788B |
| November 04, 2026 | 1.813B |
| November 03, 2026 | 1.615B |
| November 02, 2026 | 1.592B |
| October 30, 2026 | 1.629B |
| October 29, 2026 | 1.688B |
| October 28, 2026 | 1.641B |
| October 27, 2026 | 1.636B |
| October 26, 2026 | 1.505B |
| October 23, 2026 | 1.459B |
| October 22, 2026 | 1.482B |
| October 21, 2026 | 1.476B |
| October 20, 2026 | 1.409B |
| October 19, 2026 | 1.268B |
| October 16, 2026 | 1.267B |
| October 15, 2026 | 1.319B |
| October 14, 2026 | 1.265B |
| October 13, 2026 | 1.270B |
| October 12, 2026 | 1.324B |
| October 09, 2026 | 1.363B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.293B |
| October 07, 2026 | 1.250B |
| October 06, 2026 | 1.235B |
| October 05, 2026 | 1.339B |
| October 02, 2026 | 1.331B |
| October 01, 2026 | 1.347B |
| September 30, 2026 | 1.399B |
| September 29, 2026 | 1.437B |
| September 28, 2026 | 1.465B |
| September 25, 2026 | 1.375B |
| September 24, 2026 | 1.392B |
| September 23, 2026 | 1.406B |
| September 22, 2026 | 1.494B |
| September 21, 2026 | 1.410B |
| September 18, 2026 | 1.417B |
| September 17, 2026 | 1.454B |
| September 16, 2026 | 1.406B |
| September 15, 2026 | 1.425B |
| September 14, 2026 | 1.456B |
| September 11, 2026 | 1.409B |
| September 10, 2026 | 1.374B |
| September 09, 2026 | 1.384B |
| September 08, 2026 | 1.357B |
| September 04, 2026 | 1.329B |
| September 03, 2026 | 1.331B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 12.75M |
| CNBX Pharmaceuticals, Inc. | 1.305M |
| Arvinas, Inc. | -100.82M |
| Fulcrum Therapeutics, Inc. | -32.83M |
| Definium Therapeutics, Inc. | 3.507B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.59M |
| Revenue (Quarterly) | 18.88M |
| Total Expenses (Quarterly) | 45.47M |
| EPS Diluted (Quarterly) | -0.5668 |
| Gross Profit Margin (Quarterly) | 97.91% |
| Profit Margin (Quarterly) | -140.8% |
| Earnings Yield | -3.08% |
| Normalized Earnings Yield | -3.082 |